Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NASDAQ:NH - NantHealth Stock Price, Forecast & News

$1.46
+0.02 (+1.39 %)
(As of 01/22/2020 01:18 AM ET)
Today's Range
$1.37
Now: $1.46
$1.50
50-Day Range
$0.86
MA: $1.09
$1.44
52-Week Range
$0.45
Now: $1.46
$1.96
Volume178,115 shs
Average Volume417,724 shs
Market Capitalization$161.51 million
P/E RatioN/A
Dividend YieldN/A
Beta1.52
NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice. Read More…

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone310-883-1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$89.46 million
Book Value$0.03 per share

Profitability

Net Income$-192,150,000.00
Net Margins-105.82%
Return on Equity-10,106.10%

Miscellaneous

Employees543
Market Cap$161.51 million
Next Earnings Date3/26/2020 (Estimated)
OptionableOptionable

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

NantHealth (NASDAQ:NH) Frequently Asked Questions

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) posted its earnings results on Thursday, November, 7th. The company reported ($0.15) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.07) by $0.08. The business had revenue of $22.36 million for the quarter, compared to the consensus estimate of $23.40 million. NantHealth had a negative return on equity of 10,106.10% and a negative net margin of 105.82%. View NantHealth's Earnings History.

When is NantHealth's next earnings date?

NantHealth is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for NantHealth.

What price target have analysts set for NH?

1 equities research analysts have issued 1-year price objectives for NantHealth's shares. Their forecasts range from $1.00 to $1.00. On average, they expect NantHealth's stock price to reach $1.00 in the next twelve months. This suggests that the stock has a possible downside of 31.5%. View Analyst Price Targets for NantHealth.

What is the consensus analysts' recommendation for NantHealth?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.

Has NantHealth been receiving favorable news coverage?

Media coverage about NH stock has trended negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NantHealth earned a coverage optimism score of -2.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for NantHealth.

Are investors shorting NantHealth?

NantHealth saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 224,300 shares, an increase of 31.4% from the December 15th total of 170,700 shares. Based on an average daily trading volume, of 160,100 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.6% of the shares of the company are short sold. View NantHealth's Current Options Chain.

Who are some of NantHealth's key competitors?

What other stocks do shareholders of NantHealth own?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:
  • Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)
  • Mr. Ronald Allen Louks, COO & Director (Age 54)
  • Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)
  • Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
  • Mr. Charles Hunt, VP of Marketing, Communications & User Experience

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $1.46.

How big of a company is NantHealth?

NantHealth has a market capitalization of $161.51 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe.View Additional Information About NantHealth.

What is NantHealth's official website?

The official website for NantHealth is http://www.nanthealth.com/.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NASDAQ NH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  254 (Vote Outperform)
Underperform Votes:  279 (Vote Underperform)
Total Votes:  533
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel